Form 4: Ingevity Corp Director Frederick J. Lynch Reports Acquisition of 4,057 Shares of Common Stock
SEC Form 4 Filing
Director Frederick J. Lynch reported acquiring 4,057 shares of Ingevity Corp common stock through a grant of restricted stock units.
Summary
- On May 1, 2025, Frederick J. Lynch, a director of Ingevity Corp, acquired 4,057 shares of common stock.
- The acquisition was a grant of restricted stock units under the company's 2016 Omnibus Incentive Plan.
- These restricted stock units will vest in full on May 1, 2026.
- Following the transaction, Lynch directly owns 26,359 shares of Ingevity Corp common stock.
- Lynch has granted limited power of attorney to Ryan C. Fisher, Mavis G. Huger, and any duly appointed Corporate Secretary of Ingevity Corporation for SEC reporting purposes.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing a stock transaction. The acquisition of shares by a director could be interpreted slightly positively, but it's not a major event.
Positives
- The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements regarding Ingevity Corp's future performance beyond the vesting date of the restricted stock units.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their holdings in the company.
Comparison to Industry Standards
- Insider transactions are a normal part of corporate governance and are regularly disclosed by directors and officers of publicly traded companies.
- The reporting requirements are standardized by the SEC, ensuring transparency and preventing insider trading.
- Similar filings can be observed across various companies in the specialty chemicals industry, such as Celanese, Ashland, and Eastman Chemical.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it signals confidence from a company director.
Key Dates
| Date | Description |
|---|---|
| April 29, 2025 | Date of execution of the Limited Power of Attorney. |
| May 1, 2025 | Date of transaction: Acquisition of 4,057 shares of common stock. |
| May 5, 2025 | Date of signature on the Form 4 filing. |
| May 1, 2026 | Vesting date for the restricted stock units. |
Keywords
Ingevity Corp, Frederick J. Lynch, Form 4, Director, Stock Acquisition, Restricted Stock Units, Beneficial Ownership, SEC, NGVT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.